Q2 2023

Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001493152-23-028270

Q2 2023 · 10-Q

Revenue

$107.10K

+614.9% vs Q2 2022

Net Income

$71.20K

+6,504.4% vs Q2 2022

EPS, diluted—

Operating Income$71,392+6,528.8%

Operating Cash Flowderived-$37,329N/M

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$107.10K	$14.98K	—	$0.00
Net Income	$71.20K	$1.08K	-$52.74K	-$53.65K
EPS Diluted	—	—	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR